Safety and Outcome of Microincision Vitreous Surgery in Uveitis

ABSTRACT

Purpose: To report the outcome of microincision vitreous surgery (MIVS) in uveitis.

Methods: In total, 103 patients (106 eyes) underwent diagnostic MIVS between March 2012 and April 2015. Postoperative evaluation included vitreous haze grading from clinical/electronic records, best-corrected visual acuity (BCVA), and complications.

Results: Mean age was 36.8 ± 13.9 years (range: 8–80 years). Mean follow-up after MIVS was 12.2 ± 7.2 months (median 12 months). Mean vitreous haze grading was 2.39 ± 0.98 (preoperatively), 0.36 ± 0.73 postoperatively (1 week), and 0.02 ± 0.2 at 1 month (p < 0.001). Mean BCVA was 1.5 ± 1.0 logMAR preoperatively and 0.72 ± 0.68 logMAR at 1 month (p = 0.000). Postoperative complications included cataract (14.6%), rise in intraocular pressure (13.2%), vitreous hemorrhage (4.7%), hypotony (3.2%), retinal detachment (2.8%), epiretinal membrane (2.8%), and worsening of inflammation (0.9%).

Conclusions: MIVS is safe and may have a therapeutic role in uveitis.

Keywords:

• Microincisional vitrectomy
• uveitis
• vitritis

DECLARATION OF INTEREST

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

FUNDING

This study was supported by the Department of Biotechnology, New Delhi, India.

Additional information

Funding

This study was supported by the Department of Biotechnology, New Delhi, India.